<VariationArchive RecordType="classified" VariationID="837591" VariationName="NM_001110792.2(MECP2):c.1275_*863del (p.Cys425_Ter499delinsXaa)" VariationType="Deletion" Accession="VCV000837591" Version="1" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2022-09-17" DateCreated="2020-04-15" MostRecentSubmission="2020-04-15">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="849778" VariationID="837591">
      <GeneList>
        <Gene Symbol="MECP2" FullName="methyl-CpG binding protein 2" GeneID="4204" HGNC_ID="HGNC:6990" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>Xq28</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="154021573" stop="154097717" display_start="154021573" display_stop="154097717" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="153287263" stop="153363187" display_start="153287263" display_stop="153363187" Strand="-" />
          </Location>
          <OMIM>300005</OMIM>
          <Haploinsufficiency last_evaluated="2021-02-22" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=MECP2">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2021-02-22" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=MECP2">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_001110792.2(MECP2):c.1275_*863del (p.Cys425_Ter499delinsXaa)</Name>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>Xq28</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="154029504" stop="154030589" display_start="154029504" display_stop="154030589" variantLength="1086" positionVCF="154029503" referenceAlleleVCF="ATTAGGAATCCCTCTCACCCCGCTGTGCTCTGCCCGGCCTGACCCCAGGCCAGCCTGCCTGCACCTTGTCCTACTGCCTCCATGGCCTCTAGCGCCACCCGTTGGAGGACGTCCCTTGAGAATGGACCATGCCACCTCACCCTGGGCCATCCTCTCCTGTGGTTCAGGCCAGTCTACACCCAGTAGTTCAAGGGACTCCCCCCTCCTAGCCATGCCAGAGCTGGAGCAGACAGGTGCCACTTTCCTGTCCTGTGAAGCGTCCTTGCCAGTTTTGGATTGGGGCTGGTGTGGGGCCAGACTTGAGCCACCACGGGTGGGATCGCACAGGCCATAGCCACTGGTCATATCCATCTTCTCTAAAGAATCCAACTGTCTCTCCTGCCTCACACCTCCCTGTCCCAACGTGGTTGGGAGTGGGGGAGGTGGGGGGAGCTGGGGGAGCTGTAGACGGGGCACTGATGGCACCGAAAACGGGAGTGTCCTCTCAACTGCTCTGTCGCTCTGTCTCTAACGACCACATGGGGGAAAGGTTTGGGCGGGAGGGGAGGTGCCTGGTCAACAGCTTGTCTGGTCAGTAGTATCTGCAGCAAGCCTTGTTGAAGGAGCCTAGTTTAGAAAAGTGCAAAGCTACTTCTGGCCCTGGTTAGGTCTTCAACCTGACTGTGCTTGTCGGTAAGAAAAACATCCCCAATGCTCCAACTACTCCCACCCTGAAGCCACGAAACTCTAAGTTTACTGAAAGAAAAAAAAATATTTTTTATTTCAGTTAATCGGGAAGCTTTGTCAGAGCCCTACCCATAAGGAGAAGAGACAACAGCTGCCTTTATTCTTGTTGGTTTGCTTTGCAATCCGCTCCGTGTAAAGTCAGCTAACTCTCTCGGTCACGGGCGTCCGGCTGTCCACAGGCTCCTCTCTGTTTGGCCTTGGCATGGAGGATGAAACAATGTCTTTGCGCTCTCCCTCCCCTCGGTGTTTGTACTTTTCTGCGGCCGTGGCGGCGGTGGCAACCGCGGGCTGAGTCTTAGCTGGCTCCTTGGGGCAGCCGTCGCTCTCCAGTGAGCCTCCTCTGGGCATCTTCTCCTCTTTG" alternateAlleleVCF="A" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="153294955" stop="153296040" display_start="153294955" display_stop="153296040" variantLength="1086" positionVCF="153294954" referenceAlleleVCF="ATTAGGAATCCCTCTCACCCCGCTGTGCTCTGCCCGGCCTGACCCCAGGCCAGCCTGCCTGCACCTTGTCCTACTGCCTCCATGGCCTCTAGCGCCACCCGTTGGAGGACGTCCCTTGAGAATGGACCATGCCACCTCACCCTGGGCCATCCTCTCCTGTGGTTCAGGCCAGTCTACACCCAGTAGTTCAAGGGACTCCCCCCTCCTAGCCATGCCAGAGCTGGAGCAGACAGGTGCCACTTTCCTGTCCTGTGAAGCGTCCTTGCCAGTTTTGGATTGGGGCTGGTGTGGGGCCAGACTTGAGCCACCACGGGTGGGATCGCACAGGCCATAGCCACTGGTCATATCCATCTTCTCTAAAGAATCCAACTGTCTCTCCTGCCTCACACCTCCCTGTCCCAACGTGGTTGGGAGTGGGGGAGGTGGGGGGAGCTGGGGGAGCTGTAGACGGGGCACTGATGGCACCGAAAACGGGAGTGTCCTCTCAACTGCTCTGTCGCTCTGTCTCTAACGACCACATGGGGGAAAGGTTTGGGCGGGAGGGGAGGTGCCTGGTCAACAGCTTGTCTGGTCAGTAGTATCTGCAGCAAGCCTTGTTGAAGGAGCCTAGTTTAGAAAAGTGCAAAGCTACTTCTGGCCCTGGTTAGGTCTTCAACCTGACTGTGCTTGTCGGTAAGAAAAACATCCCCAATGCTCCAACTACTCCCACCCTGAAGCCACGAAACTCTAAGTTTACTGAAAGAAAAAAAAATATTTTTTATTTCAGTTAATCGGGAAGCTTTGTCAGAGCCCTACCCATAAGGAGAAGAGACAACAGCTGCCTTTATTCTTGTTGGTTTGCTTTGCAATCCGCTCCGTGTAAAGTCAGCTAACTCTCTCGGTCACGGGCGTCCGGCTGTCCACAGGCTCCTCTCTGTTTGGCCTTGGCATGGAGGATGAAACAATGTCTTTGCGCTCTCCCTCCCCTCGGTGTTTGTACTTTTCTGCGGCCGTGGCGGCGGTGGCAACCGCGGGCTGAGTCTTAGCTGGCTCCTTGGGGCAGCCGTCGCTCTCCAGTGAGCCTCCTCTGGGCATCTTCTCCTCTTTG" alternateAlleleVCF="A" />
      </Location>
      <HGVSlist>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_764" sequenceAccession="LRG_764">
            <Expression>LRG_764:g.111515_112600del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_764t1" sequenceAccession="LRG_764t1">
            <Expression>LRG_764t1:c.1275_*863del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_764p1" sequenceAccession="LRG_764p1" change="p.Cys425_Ter499delinsXaa">
            <Expression>LRG_764p1:p.Cys425_Ter499delinsXaa</Expression>
          </ProteinExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_764t2" sequenceAccession="LRG_764t2">
            <Expression>LRG_764t2:c.1239_*863del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_764p2" sequenceAccession="LRG_764p2" change="p.Cys413_Ter487delinsXaa">
            <Expression>LRG_764p2:p.Cys413_Ter487delinsXaa</Expression>
          </ProteinExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000023.10" sequenceAccession="NC_000023" sequenceVersion="10" change="g.153294955_153296040del" Assembly="GRCh37">
            <Expression>NC_000023.10:g.153294955_153296040del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000023.11" sequenceAccession="NC_000023" sequenceVersion="11" change="g.154029504_154030589del" Assembly="GRCh38">
            <Expression>NC_000023.11:g.154029504_154030589del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_007107.2" sequenceAccession="NG_007107" sequenceVersion="2" change="g.111539_112624del">
            <Expression>NG_007107.2:g.111539_112624del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_007107.3" sequenceAccession="NG_007107" sequenceVersion="3" change="g.111515_112600del">
            <Expression>NG_007107.3:g.111515_112600del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001110792.2" sequenceAccession="NM_001110792" sequenceVersion="2" change="c.1275_*863del" MANESelect="true">
            <Expression>NM_001110792.2:c.1275_*863del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001104262.1" sequenceAccession="NP_001104262" sequenceVersion="1" change="p.Cys425_Ter499delinsXaa">
            <Expression>NP_001104262.1:p.Cys425_Ter499delinsXaa</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001578" Type="stop lost" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001316337.2" sequenceAccession="NM_001316337" sequenceVersion="2" change="c.960_*863del">
            <Expression>NM_001316337.2:c.960_*863del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001303266.1" sequenceAccession="NP_001303266" sequenceVersion="1" change="p.Cys320_Ter394delinsXaa">
            <Expression>NP_001303266.1:p.Cys320_Ter394delinsXaa</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001578" Type="stop lost" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001369391.2" sequenceAccession="NM_001369391" sequenceVersion="2" change="c.960_*863del">
            <Expression>NM_001369391.2:c.960_*863del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001356320.1" sequenceAccession="NP_001356320" sequenceVersion="1" change="p.Cys320_Ter394delinsXaa">
            <Expression>NP_001356320.1:p.Cys320_Ter394delinsXaa</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001578" Type="stop lost" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001369392.2" sequenceAccession="NM_001369392" sequenceVersion="2" change="c.960_*863del">
            <Expression>NM_001369392.2:c.960_*863del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001356321.1" sequenceAccession="NP_001356321" sequenceVersion="1" change="p.Cys320_Ter394delinsXaa">
            <Expression>NP_001356321.1:p.Cys320_Ter394delinsXaa</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001578" Type="stop lost" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001369393.2" sequenceAccession="NM_001369393" sequenceVersion="2" change="c.960_*863del">
            <Expression>NM_001369393.2:c.960_*863del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001356322.1" sequenceAccession="NP_001356322" sequenceVersion="1" change="p.Cys320_Ter394delinsXaa">
            <Expression>NP_001356322.1:p.Cys320_Ter394delinsXaa</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001578" Type="stop lost" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001369394.2" sequenceAccession="NM_001369394" sequenceVersion="2" change="c.960_*863del">
            <Expression>NM_001369394.2:c.960_*863del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001356323.1" sequenceAccession="NP_001356323" sequenceVersion="1" change="p.Cys320_Ter394delinsXaa">
            <Expression>NP_001356323.1:p.Cys320_Ter394delinsXaa</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001578" Type="stop lost" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001386137.1" sequenceAccession="NM_001386137" sequenceVersion="1" change="c.570_*863del">
            <Expression>NM_001386137.1:c.570_*863del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001373066.1" sequenceAccession="NP_001373066" sequenceVersion="1" change="p.Cys190_Ter264delinsXaa">
            <Expression>NP_001373066.1:p.Cys190_Ter264delinsXaa</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001578" Type="stop lost" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001386138.1" sequenceAccession="NM_001386138" sequenceVersion="1" change="c.570_*863del">
            <Expression>NM_001386138.1:c.570_*863del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001373067.1" sequenceAccession="NP_001373067" sequenceVersion="1" change="p.Cys190_Ter264delinsXaa">
            <Expression>NP_001373067.1:p.Cys190_Ter264delinsXaa</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001578" Type="stop lost" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001386139.1" sequenceAccession="NM_001386139" sequenceVersion="1" change="c.570_*863del">
            <Expression>NM_001386139.1:c.570_*863del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001373068.1" sequenceAccession="NP_001373068" sequenceVersion="1" change="p.Cys190_Ter264delinsXaa">
            <Expression>NP_001373068.1:p.Cys190_Ter264delinsXaa</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001578" Type="stop lost" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_004992.4" sequenceAccession="NM_004992" sequenceVersion="4" change="c.1239_*863del" MANEPlusClinical="true">
            <Expression>NM_004992.4:c.1239_*863del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_004983.1" sequenceAccession="NP_004983" sequenceVersion="1" change="p.Cys413_Ter487delinsXaa">
            <Expression>NP_004983.1:p.Cys413_Ter487delinsXaa</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001578" Type="stop lost" DB="SO" />
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_001110792.2(MECP2):c.1275_*863del (p.Cys425_Ter499delinsXaa) AND Severe neonatal-onset encephalopathy with microcephaly" Accession="RCV001038963" Version="1">
        <ClassifiedConditionList TraitSetID="6528">
          <ClassifiedCondition DB="MedGen" ID="C1968556">Severe neonatal-onset encephalopathy with microcephaly</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2019-11-23" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2019-11-23" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2020-04-15" MostRecentSubmission="2020-04-15">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">10814718</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">19914908</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="6528" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="1150" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Encephalopathy, neonatal severe, due to MECP2 mutations</ElementValue>
                <XRef ID="Encephalopathy%2C+neonatal+severe%2C+due+to+MECP2+mutations/8310" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Encephalopathy, neonatal severe</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Severe neonatal-onset encephalopathy with microcephaly</ElementValue>
                <XRef ID="MONDO:0010397" DB="MONDO" />
                <XRef ID="209370" DB="Orphanet" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The spectrum of MECP2-related phenotypes in females ranges from classic Rett syndrome to variant Rett syndrome with a broader clinical phenotype (either milder or more severe than classic Rett syndrome) to mild learning disabilities; the spectrum in males ranges from severe neonatal encephalopathy to pyramidal signs, parkinsonism, and macroorchidism (PPM-X) syndrome to severe syndromic/nonsyndromic intellectual disability. Females: Classic Rett syndrome, a progressive neurodevelopmental disorder primarily affecting girls, is characterized by apparently normal psychomotor development during the first six to 18 months of life, followed by a short period of developmental stagnation, then rapid regression in language and motor skills, followed by long-term stability. During the phase of rapid regression, repetitive, stereotypic hand movements replace purposeful hand use. Additional findings include fits of screaming and inconsolable crying, autistic features, panic-like attacks, bruxism, episodic apnea and/or hyperpnea, gait ataxia and apraxia, tremors, seizures, and acquired microcephaly. Males: Severe neonatal-onset encephalopathy, the most common phenotype in affected males, is characterized by a relentless clinical course that follows a metabolic-degenerative type of pattern, abnormal tone, involuntary movements, severe seizures, and breathing abnormalities. Death often occurs before age two years.</Attribute>
                <XRef ID="NBK1497" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="Genetics Home Reference (GHR) links">MECP2-related severe neonatal encephalopathy</Attribute>
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301670</ID>
                <ID Source="BookShelf">NBK1497</ID>
              </Citation>
              <XRef ID="209370" DB="Orphanet" />
              <XRef ID="C1968556" DB="MedGen" />
              <XRef ID="MONDO:0010397" DB="MONDO" />
              <XRef Type="MIM" ID="300673" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="2367652" SubmissionDate="2020-02-06" DateLastUpdated="2020-04-15" DateCreated="2020-04-15">
        <ClinVarSubmissionID localKey="8158829|MedGen:C1968556" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001202467" DateUpdated="2020-04-15" DateCreated="2020-04-15" Type="SCV" Version="1" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2019-11-23">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">10814718</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">19914908</ID>
          </Citation>
          <Comment>This variant is a gross deletion (c.1239_*863delinsTGC) that includes the final 74 amino acids of exon 4. The 3' end of this event is confined to the 3'UTR of the MECP2 gene. While this deletion is not anticipated to result in nonsense mediated decay, it is expected to create a truncated MECP2 protein. This variant has been observed in individual(s) with clinical features of MECP2-related conditions (Invitae). In at least one individual the variant was observed to be de novo. This variant disrupts the C-terminus of the MECP2 protein. Other variant(s) that disrupt this region (p.Thr442Argfs*30, p.Gln437Alafs*49, p.Glu455Aspfs*32) have been observed in individuals with MECP2-related conditions (PMID: 19914908, 10814718). This suggests that this may be a clinically significant region of the protein. For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="MECP2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_004992.3:c.1239_*863del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Severe neonatal-onset encephalopathy with microcephaly</ElementValue>
            </Name>
            <XRef DB="MedGen" ID="C1968556" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB6933801</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="2367652" TraitType="Disease" MappingType="Name" MappingValue="Severe neonatal-onset encephalopathy with microcephaly" MappingRef="Preferred">
        <MedGen CUI="C1968556" Name="Severe neonatal-onset encephalopathy with microcephaly" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

